BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 22, 2017
View Archived Issues
AptaTargets raises funds to advance ApTOLL for acute ischemic stroke
Read More
Meaningful pain reduction seen with capsaicin formulation CNTX-4975 in Morton's neuroma
Read More
miR-21 a biomarker of visceral leishmaniasis vaccine immunogenicity
Read More
Corbin Therapeutics and Proteorex Therapeutics enter research and development collaboration
Read More
CHMP recommends approval of Insulin lispro Sanofi
Read More
GSK-2269557 effects evaluated in phase II COPD trial
Read More
Phase II results for cibinetide in patients with sarcoidosis-associated SNFL and neuropathic pain
Read More
Safety review committee approves continuation of Betalutin study
Read More
Erx Pharmaceuticals synthesizes novel celastrol derivatives
Read More
EMA validates application seeking expanded approval of Sprycel
Read More
EMA committee backs approval of Zykadia for first-line use in ALK+ NSCLC
Read More
Additional tolerability proof-of-concept data to be presented for KarXT
Read More
EMA accepts for review MAA for adalimumab biosimilar, FKB-327
Read More
Chiesi's triple combination for the treatment of COPD receives positive opinion from EMA
Read More
Topline phase III data from active-comparator ARCH study of Evenity
Read More
MSD submits application in Japan for approval of combination drug for type 2 diabetes
Read More
Articular cartilage product granted positive opinion from CHMP for European approval
Read More
Trillium Therapeutics patents compounds for CNS disorders
Read More
Midatech selects preferred candidate for the treatment of glioblastoma
Read More
AstraZeneca enrolling patients in phase I trial of AZD-9898
Read More
Recordati to acquire European rights to AstraZeneca's metoprolol-based treatments
Read More
Cardioxane receives positive CHMP opinion in Europe
Read More
MAX BioPharma discovers new hedgehog and/or CTGF inhibitors
Read More
Heptares Therapeutics presents novel CGRP receptor antagonists
Read More